Global Orally Disintegrating Tablet Excipient Market Insights and Forecast to 2027

1 Study Coverage

• 1.1 Orally Disintegrating Tablet Excipient Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Type
  • 1.4.2 Binders
  • 1.4.3 Glidents
  • 1.2.4 Diluents
  • 1.2.5 Disintegrants
  • 1.2.6 Others
• 1.3 Market by Application
  • 1.3.1 Global Orally Disintegrating Tablet Excipient Market Size Growth Rate by Application
  • 1.3.2 Anti-Psychotics Drug
  • 1.3.3 Anti-Epileptics Drug
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Orally Disintegrating Tablet Excipient Sales Estimates and Forecasts 2016-2027
• 2.2 Global Orally Disintegrating Tablet Excipient Revenue Estimates and Forecasts 2016-2027
• 2.3 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2016 VS 2021 VS 2027
• 2.4 Global Top Orally Disintegrating Tablet Excipient Regions by Sales
  • 2.4.1 Global Top Orally Disintegrating Tablet Excipient Regions by Sales (2016-2021)
  • 2.4.2 Global Top Orally Disintegrating Tablet Excipient Regions by Sales (2022-2027)
• 2.5 Global Top Orally Disintegrating Tablet Excipient Regions by Revenue
  • 2.5.1 Global Top Orally Disintegrating Tablet Excipient Regions by Revenue (2016-2021)
  • 2.5.2 Global Top Orally Disintegrating Tablet Excipient Regions by Revenue (2022-2027)
• 2.6 North America
• 2.7 Europe
• 2.8 Asia-Pacific
• 2.9 Latin America
• 2.10 Middle East & Africa

3 Competition by Manufacturers

• 3.1 Global Orally Disintegrating Tablet Excipient Sales by Manufacturers
  • 3.1.1 Global Top Orally Disintegrating Tablet Excipient Manufacturers by Sales (2016-2021)
  • 3.1.2 Global Top Orally Disintegrating Tablet Excipient Manufacturers Market Share by Sales (2016-2021)
  • 3.1.3 Global Top 10 and Top 5 Companies by Orally Disintegrating Tablet Excipient Sales in 2020
• 3.2 Global Orally Disintegrating Tablet Excipient Revenue by Manufacturers
  • 3.2.1 Global Top Orally Disintegrating Tablet Excipient Manufacturers by Revenue (2016-2021)
  • 3.2.2 Global Top Orally Disintegrating Tablet Excipient Manufacturers Market Share by Revenue (2016-2021)
  • 3.2.3 Global Top 10 and Top 5 Companies by Orally Disintegrating Tablet Excipient Revenue in 2020
• 3.3 Global Orally Disintegrating Tablet Excipient Sales Price by Manufacturers
• 3.4 Analysis of Competitive Landscape
  • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.4.3 Global Orally Disintegrating Tablet Excipient Manufacturers Geographical Distribution
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Orally Disintegrating Tablet Excipient Sales by Type
  • 4.1.1 Global Orally Disintegrating Tablet Excipient Historical Sales by Type (2016-2021)
  • 4.1.2 Global Orally Disintegrating Tablet Excipient Forecasted Sales by Type (2022-2027)
  • 4.1.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2016-2027)
• 4.2 Global Orally Disintegrating Tablet Excipient Revenue by Type
  • 4.2.1 Global Orally Disintegrating Tablet Excipient Historical Revenue by Type (2016-2021)
  • 4.2.2 Global Orally Disintegrating Tablet Excipient Forecasted Revenue by Type (2022-2027)
  • 4.2.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2016-2027)
• 4.3 Global Orally Disintegrating Tablet Excipient Price by Type
  • 4.3.1 Global Orally Disintegrating Tablet Excipient Price by Type (2016-2021)
  • 4.3.2 Global Orally Disintegrating Tablet Excipient Price Forecast by Type (2022-2027)

5 Market Size by Application

• 5.1 Global Orally Disintegrating Tablet Excipient Sales by Application
  • 5.1.1 Global Orally Disintegrating Tablet Excipient Historical Sales by Application (2016-2021)
  • 5.1.2 Global Orally Disintegrating Tablet Excipient Forecasted Sales by Application (2022-2027)
  • 5.1.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2016-2027)
• 5.2 Global Orally Disintegrating Tablet Excipient Revenue by Application
  • 5.2.1 Global Orally Disintegrating Tablet Excipient Historical Revenue by Application (2016-2021)
  • 5.2.2 Global Orally Disintegrating Tablet Excipient Forecasted Revenue by Application (2022-2027)
  • 5.2.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2016-2027)
• 5.3 Global Orally Disintegrating Tablet Excipient Price by Application
  • 5.3.1 Global Orally Disintegrating Tablet Excipient Price by Application (2016-2021)
  • 5.3.2 Global Orally Disintegrating Tablet Excipient Price Forecast by Application (2022-2027)

6 North America

• 6.1 North America Orally Disintegrating Tablet Excipient Market Size by Type
  • 6.1.1 North America Orally Disintegrating Tablet Excipient Sales by Type (2016-2027)
  • 6.1.2 North America Orally Disintegrating Tablet Excipient Revenue by Type (2016-2027)
• 6.2 North America Orally Disintegrating Tablet Excipient Market Size by Application
  • 6.2.1 North America Orally Disintegrating Tablet Excipient Sales by Application (2016-2027)
  • 6.2.2 North America Orally Disintegrating Tablet Excipient Revenue by Application (2016-2027)
• 6.3 North America Orally Disintegrating Tablet Excipient Market Size by Country
  • 6.3.1 North America Orally Disintegrating Tablet Excipient Sales by Country (2016-2027)
  • 6.3.2 North America Orally Disintegrating Tablet Excipient Revenue by Country (2016-2027)
  • 6.3.3 U.S.
  • 6.3.4 Canada

7 Europe

• 7.1 Europe Orally Disintegrating Tablet Excipient Market Size by Type
  • 7.1.1 Europe Orally Disintegrating Tablet Excipient Sales by Type (2017-2027)
  • 7.1.2 Europe Orally Disintegrating Tablet Excipient Revenue by Type (2017-2027)
• 7.2 Europe Orally Disintegrating Tablet Excipient Market Size by Application
  • 7.2.1 Europe Orally Disintegrating Tablet Excipient Sales by Application (2017-2027)
  • 7.2.2 Europe Orally Disintegrating Tablet Excipient Revenue by Application (2017-2027)
• 7.3 Europe Orally Disintegrating Tablet Excipient Market Size by Country
  • 7.3.1 Europe Orally Disintegrating Tablet Excipient Sales by Country (2017-2027)
  • 7.3.2 Europe Orally Disintegrating Tablet Excipient Revenue by Country (2017-2027)
  • 7.3.3 Germany
  • 7.3.4 France
  • 7.3.5 U.K.
  • 7.3.6 Italy
  • 7.3.7 Russia

8 Asia Pacific

• 8.1 Asia Pacific Orally Disintegrating Tablet Excipient Market Size by Type
  • 8.1.1 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Type (2018-2027)
  • 8.1.2 Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Type (2018-2027)
• 8.2 Asia Pacific Orally Disintegrating Tablet Excipient Market Size by Application
  • 8.2.1 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Application (2018-2027)
  • 8.2.2 Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Application (2018-2027)
• 8.3 Asia Pacific Orally Disintegrating Tablet Excipient Market Size by Region
  • 8.3.1 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Region (2018-2027)
  • 8.3.2 Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Region (2018-2027)
  • 8.3.3 China
  • 8.3.4 Japan
  • 8.3.5 South Korea
  • 8.3.6 India
  • 8.3.7 Australia
  • 8.3.8 Taiwan
  • 8.3.9 Indonesia
  • 8.3.10 Thailand
  • 8.3.11 Malaysia
  • 8.3.12 Philippines

9 Latin America

• 9.1 Latin America Orally Disintegrating Tablet Excipient Market Size by Type
  • 9.1.1 Latin America Orally Disintegrating Tablet Excipient Sales by Type (2019-2027)
  • 9.1.2 Latin America Orally Disintegrating Tablet Excipient Revenue by Type (2019-2027)
• 9.2 Latin America Orally Disintegrating Tablet Excipient Market Size by Application
  • 9.2.1 Latin America Orally Disintegrating Tablet Excipient Sales by Application (2019-2027)
  • 9.2.2 Latin America Orally Disintegrating Tablet Excipient Revenue by Application (2019-2027)
• 9.3 Latin America Orally Disintegrating Tablet Excipient Market Size by Country
  • 9.3.1 Latin America Orally Disintegrating Tablet Excipient Sales by Country (2019-2027)
  • 9.3.2 Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2019-2027)
  • 9.3.3 Mexico
  • 9.3.4 Brazil
  • 9.3.5 Argentina

6 Middle East and Africa

• 6.1 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size by Type
  • 6.1.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Type (2016-2027)
  • 6.1.2 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Type (2016-2027)
• 6.2 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size by Application
  • 6.2.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Application (2016-2027)
  • 6.2.2 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Application (2016-2027)
• 6.3 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size by Country
  • 6.3.1 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2016-2027)
  • 6.3.2 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2016-2027)
  • 6.3.3 Turkey
  • 6.3.4 Saudi Arabia
  • 6.3.5 U.A.E

11 Company Profiles

• 11.1 BASF
  • 11.1.1 BASF Corporation Information
  • 11.1.2 BASF Overview
  • 11.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 BASF Orally Disintegrating Tablet Excipient Product Description
  • 11.1.5 BASF Related Developments
• 11.2 JRS Pharma
  • 11.2.1 JRS Pharma Corporation Information
  • 11.2.2 JRS Pharma Overview
  • 11.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Product Description
  • 11.2.5 JRS Pharma Related Developments
• 11.3 Roquette
  • 11.3.1 Roquette Corporation Information
  • 11.3.2 Roquette Overview
  • 11.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.3.4 Roquette Orally Disintegrating Tablet Excipient Product Description
  • 11.3.5 Roquette Related Developments
• 11.4 ABF Ingredients
  • 11.4.1 ABF Ingredients Corporation Information
  • 11.4.2 ABF Ingredients Overview
  • 11.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Product Description
  • 11.4.5 ABF Ingredients Related Developments
• 11.5 DFE Pharma
  • 11.5.1 DFE Pharma Corporation Information
  • 11.5.2 DFE Pharma Overview
  • 11.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Product Description
  • 11.5.5 DFE Pharma Related Developments
• 11.6 Evonik
  • 11.6.1 Evonik Corporation Information
  • 11.6.2 Evonik Overview
  • 11.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.6.4 Evonik Orally Disintegrating Tablet Excipient Product Description
  • 11.6.5 Evonik Related Developments
• 11.7 Merck KGaA
  • 11.7.1 Merck KGaA Corporation Information
  • 11.7.2 Merck KGaA Overview
  • 11.7.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.7.4 Merck KGaA Orally Disintegrating Tablet Excipient Product Description
  • 11.7.5 Merck KGaA Related Developments
• 11.8 Ashland
  • 11.8.1 Ashland Corporation Information
  • 11.8.2 Ashland Overview
  • 11.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.8.4 Ashland Orally Disintegrating Tablet Excipient Product Description
  • 11.8.5 Ashland Related Developments
• 11.9 Meggle Pharma
  • 11.9.1 Meggle Pharma Corporation Information
  • 11.9.2 Meggle Pharma Overview
  • 11.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Product Description
  • 11.9.5 Meggle Pharma Related Developments
• 11.10 Shin-Etsu
  • 11.10.1 Shin-Etsu Corporation Information
  • 11.10.2 Shin-Etsu Overview
  • 11.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Product Description
  • 11.10.5 Shin-Etsu Related Developments
• 11.1 BASF
  • 11.1.1 BASF Corporation Information
  • 11.1.2 BASF Overview
  • 11.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.1.4 BASF Orally Disintegrating Tablet Excipient Product Description
  • 11.1.5 BASF Related Developments
• 11.12 McePharma (Vivesa holding)
  • 11.12.1 McePharma (Vivesa holding) Corporation Information
  • 11.12.2 McePharma (Vivesa holding) Overview
  • 11.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.12.4 McePharma (Vivesa holding) Product Description
  • 11.12.5 McePharma (Vivesa holding) Related Developments
• 11.13 Cargill Incorporated
  • 11.13.1 Cargill Incorporated Corporation Information
  • 11.13.2 Cargill Incorporated Overview
  • 11.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.13.4 Cargill Incorporated Product Description
  • 11.13.5 Cargill Incorporated Related Developments
• 11.14 Daicel Corporation
  • 11.14.1 Daicel Corporation Corporation Information
  • 11.14.2 Daicel Corporation Overview
  • 11.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.14.4 Daicel Corporation Product Description
  • 11.14.5 Daicel Corporation Related Developments
• 11.15 Anhui Sunhere Pharmaceutical
  • 11.15.1 Anhui Sunhere Pharmaceutical Corporation Information
  • 11.15.2 Anhui Sunhere Pharmaceutical Overview
  • 11.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Price, Revenue and Gross Margin (2016-2021)
  • 11.15.4 Anhui Sunhere Pharmaceutical Product Description
  • 11.15.5 Anhui Sunhere Pharmaceutical Related Developments

12 Value Chain and Sales Channels Analysis

• 12.1 Orally Disintegrating Tablet Excipient Value Chain Analysis
• 12.2 Orally Disintegrating Tablet Excipient Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Orally Disintegrating Tablet Excipient Production Mode & Process
• 12.4 Orally Disintegrating Tablet Excipient Sales and Marketing
  • 12.4.1 Orally Disintegrating Tablet Excipient Sales Channels
  • 12.4.2 Orally Disintegrating Tablet Excipient Distributors
• 12.5 Orally Disintegrating Tablet Excipient Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

• 13.1 Orally Disintegrating Tablet Excipient Industry Trends
• 13.2 Orally Disintegrating Tablet Excipient Market Drivers
• 13.3 Orally Disintegrating Tablet Excipient Market Challenges
• 13.4 Orally Disintegrating Tablet Excipient Market Restraints

14 Key Findings in The Global Orally Disintegrating Tablet Excipient Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details